DPC-681 blocks the protease enzyme, essential for the maturation and replication of HIV, playing a key role in highly active antiretroviral therapy (HAART). It targets HIV-1.
Molecular Weight
669.85
Molecular Formula
C35H48FN5O5S
Targets
HIV-1
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
DPC-681 is researched as an HIV protease inhibitor aimed at preventing HIV maturation within cells.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
